710 related articles for article (PubMed ID: 8813091)
1. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
Hanada T; Abe T; Takita H
Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
[TBL] [Abstract][Full Text] [Related]
3. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
[TBL] [Abstract][Full Text] [Related]
4. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory properties of antithrombin III: new therapeutic implications.
Okajima K; Uchiba M
Semin Thromb Hemost; 1998; 24(1):27-32. PubMed ID: 9515777
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
[TBL] [Abstract][Full Text] [Related]
7. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
Sobczyk J; Swietliński J; Podleśny-Owsińska T
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
[No Abstract] [Full Text] [Related]
8. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
9. Disseminated intravascular coagulation in patients with multiple organ failure of non-septic origin.
Penner JA
Semin Thromb Hemost; 1998; 24(1):45-52. PubMed ID: 9515779
[TBL] [Abstract][Full Text] [Related]
10. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
[TBL] [Abstract][Full Text] [Related]
11. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
[TBL] [Abstract][Full Text] [Related]
12. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
Jespersen J; Rasmussen NR; Sidelmann J
Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
[No Abstract] [Full Text] [Related]
13. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
[TBL] [Abstract][Full Text] [Related]
14. [Are there certified indications for the use of antithrombin III in intensive care].
Kulka PJ; Tryba M; Lange S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):143-53. PubMed ID: 11324345
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
von Kries R; Stannigel H; Göbel U
Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
[TBL] [Abstract][Full Text] [Related]
16. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
Wisecarver JL; Haire WD
Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombin III in the treatment of disseminated intravascular coagulation].
Nordgaard-Andersen I; Madsen JR
Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
[No Abstract] [Full Text] [Related]
18. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
Sacher R
Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
[No Abstract] [Full Text] [Related]
20. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
